Dr. Lloyd Devassy Panjikaran, MD

Dr. Panjikaran practices at Kentfield Hospital San Francisco in San Francisco, California.

Dr. Panjikaran's NPI, 1609372341, was assigned on April 2, 2018. Dr. Panjikaran graduated from Southern Medical University in 2013. Dr. Panjikaran holds California license A185908.

Dr. Panjikaran's primary practice is Kentfield Hospital San Francisco, at 450 Stanyan St, San Francisco, CA 94117 in San Francisco County. The practice phone is (415) 456-9680.

Dr. Panjikaran's primary practice is Kentfield Hospital San Francisco in San Francisco, California. Dr. Panjikaran is also affiliated with UCSF Health Stanyan Hospital. The medical group on file is Vituity. Dmand AI also links Dr. Panjikaran to 5 more hospitals, 8 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Panjikaran practices, 7 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Panjikaran's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Panjikaran is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Panjikaran's licenses on file in 4 states: California, Illinois, Oklahoma and Minnesota.

Dmand AI lists acute diabetes, anemia, atherosclerosis, cirrhosis, congestive heart failure, electrolyte disorders, gastrointestinal inflammation and kidney failure among the conditions Dr. Panjikaran treats.

CMS data shows 877 Medicare services from Dr. Panjikaran across 5 procedure codes in 2024, for 301 Medicare patients. Medicare paid $78,549 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 301 Medicare patients who saw Dr. Panjikaran in 2024. The largest group is 75 to 84, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Panjikaran's median patient age at 70, with 48% women.

In 2024, Dr. Panjikaran wrote 239 Medicare Part D claims for 98 patients. 85% of them were for generic drugs. CMS names the drug for 72 of them, across 5 drugs with 11 or more claims each, at $298 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Dr. Panjikaran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Panjikaran. Dr. Panjikaran's most frequent co-authors are Murthy R. Chamarthy, MD, Aju Mathew, MD and Jason Wayne Wachsmann, MD.

CMS Open Payments shows 4 general payments to Dr. Panjikaran from 4 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $100.

Dr. Panjikaran graduated from Southern Medical University in 2013.

Dr. Panjikaran is in network with 2 carriers, including CMS Medicare and HCSC. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.